Dehydration of Stenfilcon A Contact Lenses Versus Delefilcon A Contact Lenses
NCT ID: NCT02366923
Last Updated: 2020-07-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2015-04-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dehydration of Omafilcon A Contact Lenses Versus Delefilcon A Contact Lenses
NCT02366910
Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses
NCT01707238
The Clinical Comparison of Senofilcon A and Stenfilcon A Contact Lenses
NCT02643004
Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical Study
NCT02637804
Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber
NCT01482312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stenfilcon A
Each subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
stenfilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
delefilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
delefilcon A
Each subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
stenfilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
delefilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stenfilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
delefilcon A
Each subject randomized to wear either the test or control in either the left of right eye.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has read and signed an information consent letter;
3. Is willing and able to follow instructions and maintain the appointment schedule;
4. Is a current wearer of soft contact lenses and has worn them (any brand) more than 3 months.
5. Is able to wear lenses for at least 12 hours a day.
Exclusion Criteria
2. Has any known active\* ocular disease and/or infection;
3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
6. Has undergone refractive error surgery;
* \*For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lydon Jones, PhD FC
Role: PRINCIPAL_INVESTIGATOR
Director, Centre for Contact Lens Research
Farah Panjwani, BSc RAQ
Role: PRINCIPAL_INVESTIGATOR
Univerisy of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Waterloo School of Optometry
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-56
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.